 | VU0 | Name: | (1~{S},2~{R},4~{R})-2-azanylbicyclo[2.2.1]heptane-2-carboxylic acid | Formula: | C8 H13 N O2 | SMILES: | N[C]1(C[CH]2CC[CH]1C2)C(O)=O | InChi: | InChI=1S/C8H13NO2/c9-8(7(10)11)4-5-1-2-6(8)3-5/h5-6H,1-4,9H2,(H,10,11)/t5-,6+,8-/m1/s1 | Definition date: | 2023-08-18 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | (1~{S},2~{R},4~{R})-2-azanylbicyclo[2.2.1]heptane-2-carboxylic acid |
|
 | VUC | Name: | (2~{S})-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid | Formula: | C13 H18 Cl2 N2 O2 | SMILES: | N[CH](Cc1ccc(cc1)N(CCCl)CCCl)C(O)=O | InChi: | InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1 | Synonyms: | melphalan | Definition date: | 2023-08-18 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | (2~{S})-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid |
|
 | YNH | Name: | methyl 3-[2-(2,4-dimethylphenoxy)ethanoylamino]-4-(4-ethylpiperazin-1-yl)benzoate | Formula: | C24 H31 N3 O4 | SMILES: | CCN1CCN(CC1)c2ccc(cc2NC(=O)COc3ccc(C)cc3C)C(=O)OC | InChi: | InChI=1S/C24H31N3O4/c1-5-26-10-12-27(13-11-26)21-8-7-19(24(29)30-4)15-20(21)25-23(28)16-31-22-9-6-17(2)14-18(22)3/h6-9,14-15H,5,10-13,16H2,1-4H3,(H,25,28) | Definition date: | 2023-12-06 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | methyl 3-[2-(2,4-dimethylphenoxy)ethanoylamino]-4-(4-ethylpiperazin-1-yl)benzoate |
|
 | ZVA | Name: | (6M)-6-(5-cyano-1H-pyrazolo[3,4-b]pyridin-1-yl)-N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-4-[(propan-2-yl)amino]pyridine-3-carboxamide | Formula: | C21 H24 F N7 O2 | SMILES: | CC(C)(O)C(F)CNC(=O)c1cnc(cc1NC(C)C)n1ncc2cc(cnc21)C#N | InChi: | InChI=1S/C21H24FN7O2/c1-12(2)28-16-6-18(29-19-14(9-27-29)5-13(7-23)8-25-19)24-10-15(16)20(30)26-11-17(22)21(3,4)31/h5-6,8-10,12,17,31H,11H2,1-4H3,(H,24,28)(H,26,30)/t17-/m1/s1 | Definition date: | 2023-04-06 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | (6M)-6-(5-cyano-1H-pyrazolo[3,4-b]pyridin-1-yl)-N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-4-[(propan-2-yl)amino]pyridine-3-carboxamide |
|
 | ZVD | Name: | N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-[(5-fluoropyrimidin-4-yl)amino]-4-[(propan-2-yl)amino]pyridine-3-carboxamide | Formula: | C18 H24 F2 N6 O2 | SMILES: | Fc1cncnc1Nc1cc(NC(C)C)c(cn1)C(=O)NCC(F)C(C)(C)O | InChi: | InChI=1S/C18H24F2N6O2/c1-10(2)25-13-5-15(26-16-12(19)7-21-9-24-16)22-6-11(13)17(27)23-8-14(20)18(3,4)28/h5-7,9-10,14,28H,8H2,1-4H3,(H,23,27)(H2,21,22,24,25,26)/t14-/m1/s1 | Definition date: | 2023-04-06 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-[(5-fluoropyrimidin-4-yl)amino]-4-[(propan-2-yl)amino]pyridine-3-carboxamide |
|
 | ZVG | Name: | 6-[(5-cyanopyrimidin-2-yl)amino]-N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-4-[(propan-2-yl)amino]pyridine-3-carboxamide | Formula: | C19 H24 F N7 O2 | SMILES: | CC(C)(O)C(F)CNC(=O)c1cnc(Nc2ncc(cn2)C#N)cc1NC(C)C | InChi: | InChI=1S/C19H24FN7O2/c1-11(2)26-14-5-16(27-18-24-7-12(6-21)8-25-18)22-9-13(14)17(28)23-10-15(20)19(3,4)29/h5,7-9,11,15,29H,10H2,1-4H3,(H,23,28)(H2,22,24,25,26,27)/t15-/m1/s1 | Definition date: | 2023-04-06 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | 6-[(5-cyanopyrimidin-2-yl)amino]-N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-4-[(propan-2-yl)amino]pyridine-3-carboxamide |
|
 | VBL | Name: | (2~{S},3~{R})-2-pentyloctane-1,3-diol | Formula: | C13 H28 O2 | SMILES: | CCCCC[CH](O)[CH](CO)CCCCC | InChi: | InChI=1S/C13H28O2/c1-3-5-7-9-12(11-14)13(15)10-8-6-4-2/h12-15H,3-11H2,1-2H3/t12-,13+/m0/s1 | Definition date: | 2023-09-11 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | (2~{S},3~{R})-2-pentyloctane-1,3-diol |
|
 | G1V | Name: | N-[(1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl]-1-[2,6-bis(chloranyl)phenyl]carbonyl-4-[[2,6-bis(chloranyl)phenyl]carbonylamino]pyrazole-3-carboxamide | Formula: | C23 H17 Cl4 N5 O3 | SMILES: | Clc1cccc(Cl)c1C(=O)Nc2cn(nc2C(=O)NC3[CH]4CNC[CH]34)C(=O)c5c(Cl)cccc5Cl | InChi: | InChI=1S/C23H17Cl4N5O3/c24-12-3-1-4-13(25)17(12)21(33)29-16-9-32(23(35)18-14(26)5-2-6-15(18)27)31-20(16)22(34)30-19-10-7-28-8-11(10)19/h1-6,9-11,19,28H,7-8H2,(H,29,33)(H,30,34)/t10-,11+,19+ | Synonyms: | N-(3-azabicyclo[3.1.0]hexan-6-yl)-4-(2,6-dichlorobenzamido)-1-(2,6-dichlorobenzoyl)-1H-pyrazole-3-carboxamide | Definition date: | 2023-07-20 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | ~{N}-[(1~{R},5~{S})-3-azabicyclo[3.1.0]hexan-6-yl]-1-[2,6-bis(chloranyl)phenyl]carbonyl-4-[[2,6-bis(chloranyl)phenyl]carbonylamino]pyrazole-3-carboxamide |
|
 | A1ATU | Name: | 4-(3-methylanilino)-N-[(propan-2-yl)carbamoyl]pyridine-3-sulfonamide | Formula: | C16 H20 N4 O3 S | SMILES: | O=S(=O)(NC(=O)NC(C)C)c1cnccc1Nc1cc(C)ccc1 | InChi: | InChI=1S/C16H20N4O3S/c1-11(2)18-16(21)20-24(22,23)15-10-17-8-7-14(15)19-13-6-4-5-12(3)9-13/h4-11H,1-3H3,(H,17,19)(H2,18,20,21) | Definition date: | 2024-05-31 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | 4-(3-methylanilino)-N-[(propan-2-yl)carbamoyl]pyridine-3-sulfonamide |
|
 | A1AVY | Name: | 1-(5-{4-[6-(trifluoromethyl)pyridin-2-yl]piperazine-1-sulfonyl}-2,3-dihydro-1H-indol-1-yl)ethan-1-one | Formula: | C20 H21 F3 N4 O3 S | SMILES: | O=S(=O)(c1cc2CCN(C(C)=O)c2cc1)N1CCN(CC1)c1cccc(n1)C(F)(F)F | InChi: | InChI=1S/C20H21F3N4O3S/c1-14(28)27-8-7-15-13-16(5-6-17(15)27)31(29,30)26-11-9-25(10-12-26)19-4-2-3-18(24-19)20(21,22)23/h2-6,13H,7-12H2,1H3 | Definition date: | 2024-06-24 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | 1-(5-{4-[6-(trifluoromethyl)pyridin-2-yl]piperazine-1-sulfonyl}-2,3-dihydro-1H-indol-1-yl)ethan-1-one |
|
 | A1AVZ | Name: | 1-(5-{4-[4-(trifluoromethyl)pyridin-2-yl]piperazine-1-sulfonyl}-2,3-dihydro-1H-indol-1-yl)ethan-1-one | Formula: | C20 H21 F3 N4 O3 S | SMILES: | O=S(=O)(c1cc2CCN(C(C)=O)c2cc1)N1CCN(CC1)c1cc(ccn1)C(F)(F)F | InChi: | InChI=1S/C20H21F3N4O3S/c1-14(28)27-7-5-15-12-17(2-3-18(15)27)31(29,30)26-10-8-25(9-11-26)19-13-16(4-6-24-19)20(21,22)23/h2-4,6,12-13H,5,7-11H2,1H3 | Definition date: | 2024-06-24 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | 1-(5-{4-[4-(trifluoromethyl)pyridin-2-yl]piperazine-1-sulfonyl}-2,3-dihydro-1H-indol-1-yl)ethan-1-one |
|
 | A1A2Z | Name: | N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-L-tryptophan | Formula: | C19 H22 N3 O7 P | SMILES: | O=P(O)(O)OCc1cnc(C)c(O)c1CNC(Cc1c[NH]c2ccccc21)C(=O)O | InChi: | InChI=1S/C19H22N3O7P/c1-11-18(23)15(13(8-20-11)10-29-30(26,27)28)9-22-17(19(24)25)6-12-7-21-16-5-3-2-4-14(12)16/h2-5,7-8,17,21-23H,6,9-10H2,1H3,(H,24,25)(H2,26,27,28)/t17-/m0/s1 | Definition date: | 2024-08-21 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-L-tryptophan |
|
 | A1A4F | Name: | N-[3-(cyclohexylmethyl)-1H-pyrazol-5-yl]-2-[(1H-imidazol-1-yl)methyl]benzene-1-sulfonamide | Formula: | C20 H25 N5 O2 S | SMILES: | O=S(=O)(Nc1cc(CC2CCCCC2)n[NH]1)c1ccccc1Cn1ccnc1 | InChi: | InChI=1S/C20H25N5O2S/c26-28(27,19-9-5-4-8-17(19)14-25-11-10-21-15-25)24-20-13-18(22-23-20)12-16-6-2-1-3-7-16/h4-5,8-11,13,15-16H,1-3,6-7,12,14H2,(H2,22,23,24) | Definition date: | 2024-09-03 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | N-[3-(cyclohexylmethyl)-1H-pyrazol-5-yl]-2-[(1H-imidazol-1-yl)methyl]benzene-1-sulfonamide |
|
 | A1A79 | Name: | 7-[(3xi,5R)-5-C-(3,4-dichlorophenyl)-3-C-methyl-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | Formula: | C18 H18 Cl2 N4 O4 | SMILES: | Clc1ccc(cc1Cl)C(O)C1OC(n2ccc3c(N)ncnc32)C(O)C1(C)O | InChi: | InChI=1S/C18H18Cl2N4O4/c1-18(27)13(26)17(24-5-4-9-15(21)22-7-23-16(9)24)28-14(18)12(25)8-2-3-10(19)11(20)6-8/h2-7,12-14,17,25-27H,1H3,(H2,21,22,23)/t12-,13+,14-,17-,18+/m1/s1 | Definition date: | 2024-09-19 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | 7-[(3xi,5R)-5-C-(3,4-dichlorophenyl)-3-C-methyl-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
|
 | A1BQY | Name: | 1-methyl-N-{[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]methyl}-1H-indazole-3-carboxamide | Formula: | C19 H20 N4 O | SMILES: | O=C(NCC1Cc2ccccc2CN1)c1nn(C)c2ccccc21 | InChi: | InChI=1S/C19H20N4O/c1-23-17-9-5-4-8-16(17)18(22-23)19(24)21-12-15-10-13-6-2-3-7-14(13)11-20-15/h2-9,15,20H,10-12H2,1H3,(H,21,24)/t15-/m0/s1 | Definition date: | 2025-01-14 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | 1-methyl-N-{[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]methyl}-1H-indazole-3-carboxamide |
|
 | A1BQZ | Name: | 6-propanoyl-2H-1,4-benzoxazin-3(4H)-one | Formula: | C11 H11 N O3 | SMILES: | CCC(=O)c1ccc2OCC(=O)Nc2c1 | InChi: | InChI=1S/C11H11NO3/c1-2-9(13)7-3-4-10-8(5-7)12-11(14)6-15-10/h3-5H,2,6H2,1H3,(H,12,14) | Definition date: | 2025-01-14 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | 6-propanoyl-2H-1,4-benzoxazin-3(4H)-one |
|
 | A1BV9 | Name: | [(1'R)-1'-(4-{[(3S)-1-(3-fluoropropyl)-2,3-dihydro-1H-pyrrol-3-yl]methoxy}phenyl)-6'-hydroxy-1',4'-dihydro-2'H-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl](phenyl)methanone | Formula: | C32 H33 F N2 O3 | SMILES: | FCCCN1C=CC(C1)COc1ccc(cc1)C1c2ccc(O)cc2CC2(CC2)N1C(=O)c1ccccc1 | InChi: | InChI=1S/C32H33FN2O3/c33-16-4-17-34-18-13-23(21-34)22-38-28-10-7-24(8-11-28)30-29-12-9-27(36)19-26(29)20-32(14-15-32)35(30)31(37)25-5-2-1-3-6-25/h1-3,5-13,18-19,23,30,36H,4,14-17,20-22H2/t23-,30+/m0/s1 | Definition date: | 2025-02-05 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | [(1'R)-1'-(4-{[(3S)-1-(3-fluoropropyl)-2,3-dihydro-1H-pyrrol-3-yl]methoxy}phenyl)-6'-hydroxy-1',4'-dihydro-2'H-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl](phenyl)methanone |
|
 | A1D8Q | Name: | (3~{Z})-3-[[4-[bis(fluoranyl)methoxy]-3-cyclopentyloxy-phenyl]methylidene]-6-oxidanyl-1~{H}-indol-2-one | Formula: | C21 H19 F2 N O4 | SMILES: | Oc1ccc2c(NC(=O)C2=Cc3ccc(OC(F)F)c(OC4CCCC4)c3)c1 | InChi: | InChI=1S/C21H19F2NO4/c22-21(23)28-18-8-5-12(10-19(18)27-14-3-1-2-4-14)9-16-15-7-6-13(25)11-17(15)24-20(16)26/h5-11,14,21,25H,1-4H2,(H,24,26)/b16-9- | Definition date: | 2024-06-05 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | (3~{Z})-3-[[4-[bis(fluoranyl)methoxy]-3-cyclopentyloxy-phenyl]methylidene]-6-oxidanyl-1~{H}-indol-2-one |
|
 | A1EBI | Name: | (5Z)-3-(3H-benzimidazol-4-ylmethyl)-5-[[3,5-bis(fluoranyl)-4-oxidanyl-phenyl]methylidene]-2-[(E)-hydroxyiminomethyl]imidazol-4-one | Formula: | C19 H13 F2 N5 O3 | SMILES: | ON=CC1=NC(=Cc2cc(F)c(O)c(F)c2)C(=O)N1Cc3cccc4nc[nH]c34 | InChi: | InChI=1S/C19H13F2N5O3/c20-12-4-10(5-13(21)18(12)27)6-15-19(28)26(16(25-15)7-24-29)8-11-2-1-3-14-17(11)23-9-22-14/h1-7,9,27,29H,8H2,(H,22,23)/b15-6-,24-7+ | Definition date: | 2024-09-05 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | (5~{Z})-3-(3~{H}-benzimidazol-4-ylmethyl)-5-[[3,5-bis(fluoranyl)-4-oxidanyl-phenyl]methylidene]-2-[(~{E})-hydroxyiminomethyl]imidazol-4-one |
|
 | A1EG2 | Name: | 3-[2,3-bis(oxidanyl)phenyl]propanoic acid | Formula: | C9 H10 O4 | SMILES: | OC(=O)CCc1cccc(O)c1O | InChi: | InChI=1S/C9H10O4/c10-7-3-1-2-6(9(7)13)4-5-8(11)12/h1-3,10,13H,4-5H2,(H,11,12) | Definition date: | 2024-12-05 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | 3-[2,3-bis(oxidanyl)phenyl]propanoic acid |
|
 | MCO | Name: | 1-(3-MERCAPTO-2-METHYL-PROPIONYL)-PYRROLIDINE-2-CARBOXYLIC ACID | Formula: | C9 H15 N O3 S | SMILES: | OC(=O)C1CCCN1C(=O)C(C)CS | InChi: | InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7-/m1/s1 | Definition date: | 2001-08-28 | Last modified: | 2025-02-06 | Identifier: | 1-[(2S)-2-methyl-3-sulfanylpropanoyl]-D-proline |
|
 | A1LXR | Name: | Cer(d18:0/20:0) | Formula: | C38 H77 N O3 | SMILES: | CCCCCCCCCCCCCCCCCCCC(=O)N[CH](CO)[CH](O)CCCCCCCCCCCCCCC | InChi: | InChI=1S/C38H77NO3/c1-3-5-7-9-11-13-15-17-18-19-20-22-24-26-28-30-32-34-38(42)39-36(35-40)37(41)33-31-29-27-25-23-21-16-14-12-10-8-6-4-2/h36-37,40-41H,3-35H2,1-2H3,(H,39,42)/t36-,37+/m0/s1 | Synonyms: | N-(eicosanoyl)-dihydroceramide | Definition date: | 2024-02-05 | Last modified: | 2025-02-06 | Release date: | 2025-02-05 | Identifier: | ~{N}-[(2~{S},3~{R})-1,3-bis(oxidanyl)octadecan-2-yl]icosanamide |
|
 | PSE | Name: | O-PHOSPHOETHANOLAMINE | Formula: | C3 H10 N O5 P | SMILES: | O=P(O)(O)OCC(N)CO | InChi: | InChI=1S/C3H10NO5P/c4-3(1-5)2-9-10(6,7)8/h3,5H,1-2,4H2,(H2,6,7,8)/t3-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2025-02-05 | Identifier: | (2R)-2-amino-3-hydroxypropyl dihydrogen phosphate |
|
 | 9Y6 | Name: | (2E)-3-phenylprop-2-enal | Formula: | C9 H8 O | SMILES: | c1cccc(c1)C=[C@H]C=O | InChi: | InChI=1S/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4+ | Synonyms: | Trans-Cinnamaldehyde | Definition date: | 2018-08-29 | Last modified: | 2025-02-03 | Release date: | 2019-08-14 | Identifier: | (2E)-3-phenylprop-2-enal |
|
 | ZSI | Name: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2R,3S,4S)-2,3,4-trihydroxy-5-[(1R,3S,3aS,13R)-1-hydroxy-10,11-dimethyl-3-[3-(methylcarbamoyl)phenyl]-4,6-dioxo-2,3,5,6-tetrahydro-1H-benzo[g]pyrrolo[2,1-e]pteridin-8(4H)-yl]pentyl dihydrogen diphosphate (non-preferred name) | Formula: | C38 H46 N10 O17 P2 | SMILES: | CNC(=O)c1cccc(c1)C1CC(O)N2c3cc(C)c(C)cc3N(CC(O)C(O)C(O)COP(=O)(O)OP(=O)(O)OCC3OC(n4cnc5c(N)ncnc54)C(O)C3O)C3=NC(=O)NC(=O)C123 | InChi: | InChI=1S/C38H46N10O17P2/c1-16-7-21-22(8-17(16)2)48-26(51)10-20(18-5-4-6-19(9-18)33(55)40-3)38(48)35(44-37(57)45-36(38)56)46(21)11-23(49)28(52)24(50)12-62-66(58,59)65-67(60,61)63-13-25-29(53)30(54)34(64-25)47-15-43-27-31(39)41-14-42-32(27)47/h4-9,14-15,20,23-26,28-30,34,49-54H,10-13H2,1-3H3,(H,40,55)(H,58,59)(H,60,61)(H2,39,41,42)(H,45,56,57)/t20-,23-,24+,25+,26+,28-,29+,30+,34+,38-/m0/s1 | Definition date: | 2023-03-29 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2R,3S,4S)-2,3,4-trihydroxy-5-[(1R,3S,3aS,13R)-1-hydroxy-10,11-dimethyl-3-[3-(methylcarbamoyl)phenyl]-4,6-dioxo-2,3,5,6-tetrahydro-1H-benzo[g]pyrrolo[2,1-e]pteridin-8(4H)-yl]pentyl dihydrogen diphosphate (non-preferred name) |
|